ATHE Neutral Sentiment Score: 55/100
ASX ANNOUNCEMENT 15 September 2025 Notice Under Section 708A(5)(e) of the Corporations Act This notice is given by Alterity Therapeutics Limited ACN 080 699 065 (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), und
Monday, September 15, 2025 1 min read
Key Takeaway: Alterity Therapeutics Limited has issued a notice under section 708A(5)(e) of the Corporations Act regarding its issuance of fully paid ordinary shares. The notice indicates that on 15 September 2025, the company issued 1,666,666,663 shares. This announcement is part of the company's compliance with regulatory requirements in Australia.
Full Press Release Details
Notice Under Section 708A(5)(e) of the Corporations
This notice is given by Alterity Therapeutics
Limited ACN 080 699 065 (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), under section 708A(5)(e) of the
Corporations Act 2001 (Cth) (Corporations Act).
| Details of securities issued |
| Type: | Shares |
| Class/Description: | Fully paid ordinary shares |
| ASX Code: | ATH |
| Date of Issue: | 15 September 2025 |
| Number Issued: | 1,666,666,663 |
The Company gives notice pursuant to section 708A(5)(e)
of the Corporations Act that:
Alterity Therapeutics Limited ACN 080 699 065
Level 14, 350 Collins Street, Melbourne, Victoria